Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05908747
Status:
RECRUITING
Last Update Posted:
2023-07-11
First Post:
2023-05-24
Brief Title:
Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer
Sponsor:
Organization:
Tianjin Medical University Cancer Institute and Hospital